Insights into the Platelet Releasate.
From: Protein Mass Spectrometry lab, Department of Cell Biology, The Scripps Research Institute, La Jolla, California, USA.
Current pharmaceutical design
- Publish Date: 2007
- ISSN: 1873-4286
- Volume: 13
- Issue: 26
- Pages: 2640-6
- Medium: Internet
- Language: English
- Citation (JAMA): Coppinger J A, Maguire P B, et al. Insights into the Platelet Releasate.. Curr. Pharm. Des. 2007;13:2640-6
Abstract
The platelet releasate comprises of a multitude of inflammatory and vasoactive substances, which can attract atherogenic leukocytes from the circulation, activate endothelial cells and stimulate vessel growth and repair by triggering vascular cell proliferation, migration, and inflammation. Thus, platelets are believed central in the development and progression of atherosclerotic lesions and recent progress in uncovering more than 300 proteins in the thrombin-activated platelet releasate may advance our ability to understand the events involved and responses triggered in the progression of atherosclerosis. Furthermore, neutralisation of these platelet-derived pro-inflammatory factors may become an interesting means for therapeutic or preventative intervention in atherosclerosis.
Mesh Headings (Keywords): Animals, Atherosclerosis, Blood Platelets, Humans, Platelet Activation
Check for Full Text / PubMed Unique Identifier (PMID): 17897006
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.